Literature DB >> 12493554

Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.

S J Teipel1, W Bayer, G E Alexander, A L W Bokde, Y Zebuhr, D Teichberg, F Müller-Spahn, M B Schapiro, H-J Möller, S I Rapoport, H Hampel.   

Abstract

We used volumetric MRI and analysis of areas under receiver operating characteristic (ROC) curves to directly compare the extent of hippocampus-amygdala formation (HAF) and corpus callosum atrophy in patients with Alzheimer's disease (AD) in different clinical stages of dementia. Based on neuropathological studies, we hypothesized that HAF atrophy, representing allocortical neuronal degeneration, would precede atrophy of corpus callosum, representing loss of neocortical association neurons, in early AD. HAF and corpus callosum sizes were significantly reduced in 27 AD patients (37% and 16%, respectively) compared to 28 healthy controls. In mildly- and moderately-demented AD patients, the ROC derived index of atrophy was greater for HAF volume than for total corpus callosum area. The index of atrophy of posterior corpus callosum was not significantly different from HAF at mild, moderate or severe stages of dementia. In conclusion, these findings suggest a characteristic regional pattern of allocortical and neocortical neurodegeneraton in AD. Our data indicate that neuronal loss in parietotemporal cortex (represented by atrophy of corpus callosum splenium) may occur simultaneously with allocortical neurodegeneration in mild AD. Moreover, ROC analysis may provide a statistical framework to determine atrophy patterns of different brain structures in neurodegenerative diseases in vivo.

Entities:  

Mesh:

Year:  2003        PMID: 12493554     DOI: 10.1016/s0197-4580(02)00044-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  23 in total

1.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

2.  Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study.

Authors:  Y Likitjaroen; T Meindl; U Friese; M Wagner; K Buerger; H Hampel; S J Teipel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-08-05       Impact factor: 5.270

3.  Regionally selective atrophy after traumatic axonal injury.

Authors:  Matthew A Warner; Teddy S Youn; Tommy Davis; Alvin Chandra; Carlos Marquez de la Plata; Carol Moore; Caryn Harper; Christopher J Madden; Jeffrey Spence; Roderick McColl; Michael Devous; Richard D King; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2010-07-12

4.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

5.  Progression of corpus callosum atrophy in early stage of Alzheimer's disease: MRI based study.

Authors:  Minwei Zhu; Wenpeng Gao; Xudong Wang; Chen Shi; Zhiguo Lin
Journal:  Acad Radiol       Date:  2012-02-18       Impact factor: 3.173

6.  Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.

Authors:  Paul J Wang; Andrew J Saykin; Laura A Flashman; Heather A Wishart; Laura A Rabin; Robert B Santulli; Tara L McHugh; John W MacDonald; Alexander C Mamourian
Journal:  Neurobiol Aging       Date:  2005-11-04       Impact factor: 4.673

7.  Corpus callosum shape changes in early Alzheimer's disease: an MRI study using the OASIS brain database.

Authors:  Babak A Ardekani; Alvin H Bachman; Khadija Figarsky; John J Sidtis
Journal:  Brain Struct Funct       Date:  2013-01-16       Impact factor: 3.270

8.  [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

Authors:  T Möller; C Born; M F Reiser; H-J Möller; H Hampel; S J Teipel
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

9.  Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death.

Authors:  Mariana Pehar; Kenneth J O'Riordan; Melissa Burns-Cusato; Matthew E Andrzejewski; Carlos Gil del Alcazar; Corinna Burger; Heidi Scrable; Luigi Puglielli
Journal:  Aging Cell       Date:  2010-04       Impact factor: 9.304

Review 10.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.